article thumbnail

This Ultra-High-Yield Dividend Stock is a Tale of 2 Portfolios

The Motley Fool

While the healthcare REIT has a fairly well-diversified portfolio, it has become a tale of two portfolios. It's the best of times for its international portfolio and those in the U.S. not leased to Steward Health Care or Prospect Medical Holdings. The healthy portfolio Medical Properties Trust owned about $17.4

article thumbnail

Taiwan Semiconductor Feels Confident About Its Long-Term Prospects

The Motley Fool

Fool.com contributor Parkev Tatevosian highlights why Taiwan Semiconductor Manufacturing (NYSE: TSM) feels so strongly about its growth prospects. Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month.

Prospects 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SoundHound AI Is Optimistic About Its Long-Term Prospects to 2025 and Beyond

The Motley Fool

Fool.com contributor Parkev Tatevosian elaborates on SoundHound AI 's (NASDAQ: SOUN) longer-term prospects. Before you buy stock in SoundHound AI, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SoundHound AI wasn’t one of them.

Prospects 130
article thumbnail

Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite

The Motley Fool

Some investors thought GLP-1 medicines such as Ozempic could decrease demand for some of Abbott's key products. Abbott's prospects remain strong Abbott Laboratories has an excellent track record of developing innovative medical devices. Here's the bottom line: Abbott Laboratories is still a top pick for long-term investors.

Prospects 130
article thumbnail

40% of Warren Buffett's $379 Billion Portfolio Is Invested in Only 1 Stock

The Motley Fool

The Oracle of Omaha's fantastic track record allocating capital at Berkshire Hathaway has made him an investing legend whose portfolio holdings are considered potential buying opportunities for individuals. Apple now represents a jaw-dropping 40% of Berkshire's entire portfolio. Is it too late to buy Apple stock? through fiscal 2026.

article thumbnail

These are Some of the Top Holdings in Billionaire Investor Bill Ackman's Portfolio. Time to Buy?

The Motley Fool

Let's dig into Ackman's reasons for sticking with these stocks and whether investors can still expect market-beating returns from here. These qualities explain why the stock has earned such a large position for Pershing Square's investment portfolio. Investors have high growth expectations for Universal.

article thumbnail

3 Stocks to Consider Adding to Your Retirement Portfolio in April

The Motley Fool

On that note, here's a look at three compelling stock prospects that may prove particularly well-suited for retirement portfolios. However, most investors would be hard-pressed to name a single drug it makes -- the company just doesn't proverbially "swing for the fences" when it comes to R&D or acquisitions.